Navigation Links
Biotech Survives Market Turbulence in November
Date:12/3/2007

he most promising biotech drugs will be intense.

"Among the glut of transactions during November was Glaxo's acquisition of privately-held Reliant Pharmaceuticals for $1.65 billion and Pfizer's acquisition of Coley Pharmaceuticals for $164 million. Reliant was planning $400 million initial public offering and its decision to be acquired provided a major premium for the company's investors.

"The environment for M&A is bullish right now... so much so that biotech's are planting 'for sale' signs on their lots," Burrill explained. "Following Biogen Idec, which put itself up for sale last month, Vancouver-based QLT said it was seeking potential buyers for some or all of its assets and MGI Pharma announced that it was looking at its options including a buyer."

Biotech IPOs

The uncertain capital markets weighed on biotech companies hoping to move off the IPO runway. In November only ARYx Therapeutics, which re-engineers commercially successful drugs to eliminate safety issues, priced a 5 million share offering at $10 -- significantly lower than its original $14 to $16 range.

Two other companies added themselves to the runway: Aegerion Pharmaceuticals, Inc. that is focused on development of small-molecule therapeutics to treat cardiovascular and metabolic disease; and ChemoCentryx, which is developing therapeutics targeting chemokine receptors to prevent autoimmune disorders and certain cancers.

Biotech Indices

"With one month to go the Burrill Biotech Select Index is up 16.6% year- to-date, well ahead of the Dow and Nasdaq. This is an excellent return considering the ongoing uncertainties in the general markets," said Burrill.

Major movers in the Biotech Select Index in November were Neurocrine Biosciences (up 41%) and Millennium Pharmaceuticals Inc. (up 25%). At one point shares of Millennium hit a new annual high amid a sharp rise in revenues for their cancer drug Velcade and upcoming Phase III trial data in multipl
'/>"/>

SOURCE Burrill & Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
3. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
4. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
5. Finkelstein Thompson LLP Announces GPC Biotech AG Investigation
6. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
7. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
8. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
9. Shareholder Class Action Filed Against GPC Biotech AG by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
10. Favrille CEO to Present at NewsMakers in the Biotech Industry Investment Conference
11. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... OH (PRWEB) November 25, 2014 Miles ... has joined the Graphel Carbon Products team as Sales/Marketing ... sales, marketing, and customer service for the graphite industry. ... Miles to our team,” stated Dave Trinkley, VP of ... “His wide range of experience in the graphite industry, ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 CURE™ ... recognition reception on December 5, 2014, in San Francisco ... The MPN Heroes event will honor clinicians, caregivers, and ... of myeloproliferative neoplasms (MPNs). , Special guest speaker ... his family's cancer journey at the reception. Over ...
(Date:11/26/2014)... Theravalues Corporation est fier d,annoncer le ... au salon Hi Europe 2014 (du 2 au ... Curcumine la plus biodisponible actuellement sur le ... des ingrédients approuvés par les règlements européens. ... dans la racine de curcuma ( Curcuma longa ...
(Date:11/26/2014)... /PRNewswrie/ -- Theravalues Corporation annuncia con orgoglio il lancio ... di Hi Europe 2014 (dal 2 al 4 dicembre, ... della curcumina con la maggiore biodisponibilità di sempre, con ... approvati dalle norme europee. La curcumina è ... ( Curcuma longa ) che è stata associata con ...
Breaking Biology Technology:Miles Holder Joins Graphel Corporation as Sales/Marketing Manager 2CURE Magazine and Incyte to Honor MPN Heroes 2CURE Magazine and Incyte to Honor MPN Heroes 3CURE Magazine and Incyte to Honor MPN Heroes 4La curcumine présentant la plus haute biodisponibilité bientôt en vente en Europe 2La curcumine présentant la plus haute biodisponibilité bientôt en vente en Europe 3La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 2La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 3
... 2011 Children,s Oncology Group (COG) and ... jointly investigate Apeiron,s APN301 in a clinical phase II ... AG (Apeiron) and the Children,s Oncology Group (COG) today ... study in neuroblastoma patients. Neuroblastoma, a cancer of the ...
... DIEGO, Calif., Sept. 29, 2011 ... innovative therapeutics for diseases and disorders of the ... presented positive new data from a Phase 1b ... in patients with Meniere,s disease.  The presented data ...
... Research Management, (ClinicalRM) a full-service Contract Research Organization ... trials, and regulatory support, announced today it was ... Center (NMRC) under its Omnibus III program. The ... of NMRC, including: providing an infrastructure of personnel, ...
Cached Biology Technology:Children's Oncology Group and Apeiron to Jointly Conduct Phase II Study in Neuroblastoma With hu14.18-IL2 (APN301) 2Children's Oncology Group and Apeiron to Jointly Conduct Phase II Study in Neuroblastoma With hu14.18-IL2 (APN301) 3Children's Oncology Group and Apeiron to Jointly Conduct Phase II Study in Neuroblastoma With hu14.18-IL2 (APN301) 4Otonomy Presents Positive New Findings From Phase 1b Study of OTO-104 in Meniere's Disease at International Conference 2Otonomy Presents Positive New Findings From Phase 1b Study of OTO-104 in Meniere's Disease at International Conference 3Otonomy Presents Positive New Findings From Phase 1b Study of OTO-104 in Meniere's Disease at International Conference 4Otonomy Presents Positive New Findings From Phase 1b Study of OTO-104 in Meniere's Disease at International Conference 5ClinicalRM Awarded Omnibus III Contracts to Support the Navy Medical Research Center (NMRC) 2ClinicalRM Awarded Omnibus III Contracts to Support the Navy Medical Research Center (NMRC) 3
(Date:11/7/2014)... professor, biomedical engineering, in the Grove School of ... have identified a molecule that could lead to ... forms of breast cancer. , Triple negative breast ... to aggressive proliferation and metastasis and a lack ... discovered the overexpression of intercellular adhesion molecule-1 (ICAM-1) ...
(Date:11/6/2014)... occur because of metastasis, yet progress in preventing ... , "It,s been particularly challenging to design drugs ... fellow in systems biology at Harvard Medical School. ... after they,ve already metastasized." , Gujral and colleagues ... help researchers better understand how metastasis begins. Their ...
(Date:11/5/2014)... – Kelly Redmond has dedicated his career to ... to a general audience. , As deputy director ... Center at Nevada,s Desert Research Institute, Redmond has ... management, application and dissemination of climate data to ... Fall Meeting in San Francisco on December 15-19, ...
Breaking Biology News(10 mins):Migration negation 2Migration negation 3Nevada climatologist to be honored at AGU Fall Meeting for lifetime of public outreach 2
... Illinois chemists have used DNA to do a protein,s job, ... biology, chemistry and medicine than ever before. Led by ... University of Illinois at Urbana-Champaign, the researchers published their findings in ... . Ideally, researchers would like to be able to ...
... phenomenon of adoption has taxed the minds of evolutionary scientists ... selection. According to Richard Dawkins,s description, adoption is "a ... fail to increase, your own reproductive success, but you improve ... to take care of young that are not related to ...
... German Research Foundation) is establishing eight new Research Units. ... 2013 March meeting in Bonn. The research collaborations will ... issues in their research areas and to establish innovative ... the new units will be interdisciplinary and span multiple ...
Cached Biology News:DNA catalysts do the work of protein enzymes 2Risk management in fish: How cichlids prevent their young from being eaten 2DFG establishes 8 new research units 2DFG establishes 8 new research units 3DFG establishes 8 new research units 4DFG establishes 8 new research units 5
Required to perform reference file generation, flatfield calibration and performance verification processes on the GSD-501...
... Amplification Kit, 100 reactions. Prepare circular ... 4-6 h.Generate microgram quantities of template ... material.Use amplified DNA directly for cycle ... or M13 liquid cultures, colonies, plaques, ...
... Microplate Rack inserts fit ... Rack, and allow you to ... capacity, shake deepwell format plates ... many plates from the shaker ...
BD FastImmune EDTA Solution. Applications: Flow Cytometry Storage Temperature: Refrigerate(2 to 8C)...
Biology Products: